Pediatric Clinical Trials Market Size, Share & Trends Analysis Report By Phase (Phase II, IV), By Study Design (Treatment, Observational Studies), By Therapeutic Areas (Mental Health Disorders, Oncology), And Segment Forecasts, 2022 - 2030
This report can be delivered to the clients within 3 Business Days
Pediatric Clinical Trials Market Growth & Trends
The global pediatric clinical trials market size is expected to reach USD 23.6 billion by 2030, according to a new report by Grand View Research, Inc., registering a CAGR of 5.1% over the forecast period. The market is growing on account of the rise in the number of pediatric clinical studies globally. As per the BMC journal, between January 2008 and December 2010, 7,029 pediatric clinical trials were registered. Whereas, between January 2017 and December 2019, the number of registered pediatric clinical trials was 11,738, which certainly reflects a significant surge in the total number of trials across the industry. The treatment options for COVID-19 pediatric patients were limited at the start of the pandemic, owing to which, in May 2020, FDA granted an Emergency Use Authorization (EUA) for Veklury (remdesivir), which could be used for the treatment of COVID-19 in adults and children.
Similarly, Convalescent plasma was also granted an EUA from the FDA for the treatment of children and adults with COVID-19. Such actions by the regulatory agencies are likely to promote the demand for pediatric clinical trials. Furthermore, increasing efforts by several government bodies to support the clinical research pertaining to pediatric diseases has further supported the market growth. For instance, in March 2022, the National Cancer Institute launched the Molecular Characterization Initiative for pediatric tumors. The Initiative is offered through NCI’s Childhood Cancer Data Initiative, which was formed to promote data sharing and collection of new data among researchers who study pediatric oncology.
In addition, the increasing prevalence of pediatric cancer is another significant factor supporting the market as well as the oncology segment’s growth. For instance, as stated by the American Society of Clinical Oncology (ASCO)in February 2022, in the U.S., an estimated 10,470 children are younger than 15 years of age and about 5,480 teens aged 15 to 19 years will be diagnosed with cancer by the end of 2022. The WHO states that diarrhea, malaria, pneumonia, and sepsis are the leading causes of death among children between the age of 1 month and 9 years The high burden of these diseases is contributing to the demand for new treatment opinions. Thus, is likely to have a positive impact on the market growth. Apart from the high burden of infectious diseases, a significant number of children also suffer from diabetes.
For instance, according to the U.S. CDC, over 26.9 million in the U.S. were diagnosed with diabetes in 2018, which included 210,000 children and adolescents younger than age 20—or 25 years. Commercially, COVID19 vaccines were majorly focused on immunizing adults aged 18 years and above, this created a high risk of disease among children below the age of 18 years. The ClinicalTrial.GOV reports that as on 4th May 2022, over 1000 studies were in the active stage for treating and diagnosing COVID-19 for pediatric patients. The burden of COVID-19 among the kids is likely to promote the demand for COVID-19 vaccine trials for pediatrics from 2021.
Pediatric Clinical Trials Market Report Highlights
Pediatric Clinical Trials Market Growth & Trends
The global pediatric clinical trials market size is expected to reach USD 23.6 billion by 2030, according to a new report by Grand View Research, Inc., registering a CAGR of 5.1% over the forecast period. The market is growing on account of the rise in the number of pediatric clinical studies globally. As per the BMC journal, between January 2008 and December 2010, 7,029 pediatric clinical trials were registered. Whereas, between January 2017 and December 2019, the number of registered pediatric clinical trials was 11,738, which certainly reflects a significant surge in the total number of trials across the industry. The treatment options for COVID-19 pediatric patients were limited at the start of the pandemic, owing to which, in May 2020, FDA granted an Emergency Use Authorization (EUA) for Veklury (remdesivir), which could be used for the treatment of COVID-19 in adults and children.
Similarly, Convalescent plasma was also granted an EUA from the FDA for the treatment of children and adults with COVID-19. Such actions by the regulatory agencies are likely to promote the demand for pediatric clinical trials. Furthermore, increasing efforts by several government bodies to support the clinical research pertaining to pediatric diseases has further supported the market growth. For instance, in March 2022, the National Cancer Institute launched the Molecular Characterization Initiative for pediatric tumors. The Initiative is offered through NCI’s Childhood Cancer Data Initiative, which was formed to promote data sharing and collection of new data among researchers who study pediatric oncology.
In addition, the increasing prevalence of pediatric cancer is another significant factor supporting the market as well as the oncology segment’s growth. For instance, as stated by the American Society of Clinical Oncology (ASCO)in February 2022, in the U.S., an estimated 10,470 children are younger than 15 years of age and about 5,480 teens aged 15 to 19 years will be diagnosed with cancer by the end of 2022. The WHO states that diarrhea, malaria, pneumonia, and sepsis are the leading causes of death among children between the age of 1 month and 9 years The high burden of these diseases is contributing to the demand for new treatment opinions. Thus, is likely to have a positive impact on the market growth. Apart from the high burden of infectious diseases, a significant number of children also suffer from diabetes.
For instance, according to the U.S. CDC, over 26.9 million in the U.S. were diagnosed with diabetes in 2018, which included 210,000 children and adolescents younger than age 20—or 25 years. Commercially, COVID19 vaccines were majorly focused on immunizing adults aged 18 years and above, this created a high risk of disease among children below the age of 18 years. The ClinicalTrial.GOV reports that as on 4th May 2022, over 1000 studies were in the active stage for treating and diagnosing COVID-19 for pediatric patients. The burden of COVID-19 among the kids is likely to promote the demand for COVID-19 vaccine trials for pediatrics from 2021.
Pediatric Clinical Trials Market Report Highlights
- The observational segment is expected to witness a considerable growth rate over the forecast period. These studies are done to investigate rare outcomes of the treatment and to detect unusual adverse effects. Such factors are driving the demand for observational studies in pediatrics
- The Phase II segment accounted for the largest share in 2021. Phase II studies consist of a high number of pediatric subjects; moreover, studies in this phase are more complex than that in other phases. Such factors are contributed to the segment's high share
- Based on therapeutic area, the oncology segment accounted for the largest share in 2021, after the others segment, owing to the high burden of cancer among the pediatrics, thus contributing to the demand for clinical studies
- Asia Pacific is projected to witness the fastest CAGR during the forecast years owing to the high population of the region, which contributes to the demand for new treatments
CHAPTER 1 METHODOLOGY AND SCOPE
1.1 Market Segmentation & Scope
1.1.1 Estimates and Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 GVR's Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (model 1)
1.6.2 Volume Price Analysis (model 2)
1.7 List of Secondary Sources
1.8 List of Primary Sources
1.9 List of Abbreviations
1.10 Objectives
1.10.1 Objective - 1:
1.10.2 Objective - 2:
1.10.3 Objective - 3:
1.10.4 Objective - 4:
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Outlook
CHAPTER 3 PEDIATRIC CLINICAL TRIALS MARKET: VARIABLES, TRENDS, & SCOPE
3.1 Market Segmentation and Scope
3.2 Market Dynamics
3.2.1 Market Driver Analysis
3.2.1.1 Growth in the number of pediatric clinical trials
3.2.1.2 Rising investment in R&D by the pharmaceutical companies
3.2.1.3 High burden of chronic and infectious diseases among the children.
3.2.2 Market Restraint Analysis
3.2.2.1 High cost of clinical studies
3.2.2.2Regulations in New Drug Development
3.3 Penetration & Growth Prospect Mapping
3.4 COVID-19 Impact on the Market
3.5 Major Deals and Strategic Alliances Analysis
3.6 Pediatric Clinical Trials: Market Analysis Tools
3.6.1 Industry Analysis - Porter’s
3.6.3 PESTEL Analysis
CHAPTER 4 PEDIATRIC CLINICAL TRIALS MARKET: PHASE ANALYSIS
4.1 Pediatric Clinical Trials market: Definition & Scope
4.2 Pediatric clinical trials: Market Share Analysis, 2021 & 2030
4.3 Phase I
4.3.1 Phase I Market, 2018 - 2030 (USD Million)
4.4 Phase II
4.4.1 Phase II market, 2018 - 2030 (USD Million)
4.5 Phase III
4.5.1 Phase III market, 2018 - 2030 (USD Million)
4.6. Phase IV
4.6.1 Phase IV market, 2018 - 2030 (USD Million)
CHAPTER 5 PEDIATRIC CLINICAL TRIALS MARKET: STUDY DESIGN ANALYSIS
5.1 Pediatric Clinical Trials market: Definition & Scope
5.2 Pediatric Clinical Trials : Market Share Analysis, 2021 & 2030
5.3 Treatment Studies
5.3.1 Treatment Studies Market, 2018 - 2030 (USD Million)
5.4. Observational Studies
5.4.1 Observational Studies market, 2018 - 2030 (USD Million)
CHAPTER 6 PEDIATRIC CLINICAL TRIALS MARKET: THERAPEUTIC AREA ANALYSIS
6.1 Pediatric Clinical Trials market: Definition & Scope
6.2 Pediatric Clinical Trials : Market Share Analysis, 2021 & 2030
6.3 Infectious Disease
6.3.1 Infectious Disease Market, 2018 - 2030 (USD Million)
6.4. Oncology
6.4.1 Oncology market, 2018 - 2030 (USD Million)
6.5 Autoimmune/Inflammatory Diseases
6.5.1. Autoimmune / inflammatory diseasesmarket, 2018 - 2030 (USD Million)
6.6 Respiratory Disorders
6.6.1 Respiratory disorders disorders market, 2018 - 2030 (USD Million)
6.7 Mental Health Disorders
6.7.1. Mental health disorders disorders market, 2018 - 2030 (USD Million)
6.8 Others
6.8.1. Others market, 2018 - 2030 (USD Million)
CHAPTER 7 PEDIATRIC CLINICAL TRIALS MARKET: REGIONAL ANALYSIS
7.1 Pediatric Clinical Trials : Market Share Analysis
7.2 North America
7.2.1 North America Pediatric clinical trials market, 2018 - 2030 (USD Million)
7.2.2 U.S.
7.2.2.1 U.S. Pediatric clinical trials market, 2018 - 2030 (USD Million)
7.2.3 Canada
7.2.3.1 Canada Pediatric clinical trials market, 2018 - 2030 (USD Million)
7.3 Europe
7.3.1 Europe Pediatric clinical trials market, 2018 - 2030 (USD Million)
7.3.2 U.K.
7.3.2.1 U.K. Pediatric clinical trials market, 2018 - 2030 (USD Million)
7.3.3 Germany
7.3.3.1 Germany Pediatric clinical trials market, 2018 - 2030 (USD Million)
7.3.4 France
7.3.4.1 France Pediatric clinical trials market, 2018 - 2030 (USD Million)
7.3.5 Italy
7.3.5.1 Italy Pediatric clinical trials market, 2018 - 2030 (USD Million)
7.3.6 Spain
7.3.6.1 Spain Pediatric clinical trials market, 2018 - 2030(USD Million)
7.4 Asia Pacific
7.4.1 Asia Pacific Pediatric clinical trials market, 2018 - 2030 (USD Million)
7.4.2 India
7.4.2.1 India Pediatric clinical trials market, 2018 - 2030 (USD Million)
7.4.3 Japan
7.4.3.1 Japan Pediatric clinical trials market, 2018 - 2030 (USD Million)
7.4.4 China
7.4.4.1 China Pediatric clinical trials market, 2018 - 2030 (USD Million)
7.4.5 Thailand
7.4.5.1 Thailand Pediatric clinical trials market, 2018 - 2030 (USD Million)
7.4.6 South Korea
7.4.6.1 South Korea Pediatric clinical trials market, 2018 - 2030 (USD Million)
7.5 Latin America
7.5.1 Latin America Pediatric clinical trials market, 2018 - 2030 (USD Million)
7.5.2 Brazil
7.5.2.1 Brazil Pediatric clinical trials market, 2018 - 2030 (USD Million)
7.5.3 Mexico
7.5.3.1 Mexico Pediatric clinical trials market, 2018 - 2030 (USD Million)
7.5.4 Argentina
7.5.4.1 Argentina Pediatric clinical trials market, 2018 - 2030 (USD Million)
7.5.5 Colombia
7.5.5.1 Colombia Pediatric clinical trials market, 2018 - 2030 (USD Million)
7.6 MEA
7.6.1 MEA Pediatric clinical trials market, 2018 - 2030 (USD Million)
7.6.2 South Africa
7.6.2.1 South Africa Pediatric clinical trials market, 2018 - 2030 (USD Million)
7.6.3 Saudi Arabia
7.6.3.1 Saudi Arabia Pediatric clinical trials market, 2018 - 2030 (USD Million)
7.6.4 UAE
7.6.4.1 UAE Pediatric clinical trials market, 2018 - 2030 (USD Million)
CHAPTER 8 COMPANY PROFILES
8.1 Company Profiles
8.1.1 ICON plc
8.1.1.1 Company overview
8.1.1.2 Financial performance
8.1.1.3 Service benchmarking
8.1.2 Syneos Health
8.1.2.1 Company overview
8.1.2.2 Financial performance
8.1.2.3 Service benchmarking
8.1.2.4 Strategic initiatives
8.1.3 Medpace, Inc.
8.1.3.1 Company overview
8.1.3.2 Financial performance
8.1.3.3 Product benchmarking
8.1.3.4 Strategic initiatives
8.1.4 PPD Inc.
8.1.4.1 Company overview
8.1.4.2 Product benchmarking
8.1.4.3 Strategic initiatives
8.1.5 Premier Research
8.1.5.1 Company overview
8.1.5.2 Product benchmarking
8.1.5.3 Strategic initiatives
8.1.6 LabCorp Drug Development
8.1.6.1 Company overview
8.1.6.2 Financial performance
8.1.6.3 Product benchmarking
8.1.6.4 Strategic initiatives
8.1.7 QPS Holdings.
8.1.7.1 Company overview
8.1.7.2 Financial performance
8.1.7.3 Product benchmarking
8.1.8 Pfizer Inc.
8.1.8.1 Company overview
8.1.8.2 Financial performance
8.1.8.3 Product benchmarking
8.1.9 The Emmes Company, LLC
8.1.9.1 Company overview
8.1.9.2 Financial performance
8.1.9.3 Product benchmarking
8.1.9.4 Strategic Initiatives
8.1.10 IQVIA Inc.
8.1.10.1 Company overview
8.1.10.2 Financial performance
8.1.10.3 Product benchmarking
8.1.10.4 Strategic Initiatives
1.1 Market Segmentation & Scope
1.1.1 Estimates and Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 GVR's Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (model 1)
1.6.2 Volume Price Analysis (model 2)
1.7 List of Secondary Sources
1.8 List of Primary Sources
1.9 List of Abbreviations
1.10 Objectives
1.10.1 Objective - 1:
1.10.2 Objective - 2:
1.10.3 Objective - 3:
1.10.4 Objective - 4:
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Outlook
CHAPTER 3 PEDIATRIC CLINICAL TRIALS MARKET: VARIABLES, TRENDS, & SCOPE
3.1 Market Segmentation and Scope
3.2 Market Dynamics
3.2.1 Market Driver Analysis
3.2.1.1 Growth in the number of pediatric clinical trials
3.2.1.2 Rising investment in R&D by the pharmaceutical companies
3.2.1.3 High burden of chronic and infectious diseases among the children.
3.2.2 Market Restraint Analysis
3.2.2.1 High cost of clinical studies
3.2.2.2Regulations in New Drug Development
3.3 Penetration & Growth Prospect Mapping
3.4 COVID-19 Impact on the Market
3.5 Major Deals and Strategic Alliances Analysis
3.6 Pediatric Clinical Trials: Market Analysis Tools
3.6.1 Industry Analysis - Porter’s
3.6.3 PESTEL Analysis
CHAPTER 4 PEDIATRIC CLINICAL TRIALS MARKET: PHASE ANALYSIS
4.1 Pediatric Clinical Trials market: Definition & Scope
4.2 Pediatric clinical trials: Market Share Analysis, 2021 & 2030
4.3 Phase I
4.3.1 Phase I Market, 2018 - 2030 (USD Million)
4.4 Phase II
4.4.1 Phase II market, 2018 - 2030 (USD Million)
4.5 Phase III
4.5.1 Phase III market, 2018 - 2030 (USD Million)
4.6. Phase IV
4.6.1 Phase IV market, 2018 - 2030 (USD Million)
CHAPTER 5 PEDIATRIC CLINICAL TRIALS MARKET: STUDY DESIGN ANALYSIS
5.1 Pediatric Clinical Trials market: Definition & Scope
5.2 Pediatric Clinical Trials : Market Share Analysis, 2021 & 2030
5.3 Treatment Studies
5.3.1 Treatment Studies Market, 2018 - 2030 (USD Million)
5.4. Observational Studies
5.4.1 Observational Studies market, 2018 - 2030 (USD Million)
CHAPTER 6 PEDIATRIC CLINICAL TRIALS MARKET: THERAPEUTIC AREA ANALYSIS
6.1 Pediatric Clinical Trials market: Definition & Scope
6.2 Pediatric Clinical Trials : Market Share Analysis, 2021 & 2030
6.3 Infectious Disease
6.3.1 Infectious Disease Market, 2018 - 2030 (USD Million)
6.4. Oncology
6.4.1 Oncology market, 2018 - 2030 (USD Million)
6.5 Autoimmune/Inflammatory Diseases
6.5.1. Autoimmune / inflammatory diseasesmarket, 2018 - 2030 (USD Million)
6.6 Respiratory Disorders
6.6.1 Respiratory disorders disorders market, 2018 - 2030 (USD Million)
6.7 Mental Health Disorders
6.7.1. Mental health disorders disorders market, 2018 - 2030 (USD Million)
6.8 Others
6.8.1. Others market, 2018 - 2030 (USD Million)
CHAPTER 7 PEDIATRIC CLINICAL TRIALS MARKET: REGIONAL ANALYSIS
7.1 Pediatric Clinical Trials : Market Share Analysis
7.2 North America
7.2.1 North America Pediatric clinical trials market, 2018 - 2030 (USD Million)
7.2.2 U.S.
7.2.2.1 U.S. Pediatric clinical trials market, 2018 - 2030 (USD Million)
7.2.3 Canada
7.2.3.1 Canada Pediatric clinical trials market, 2018 - 2030 (USD Million)
7.3 Europe
7.3.1 Europe Pediatric clinical trials market, 2018 - 2030 (USD Million)
7.3.2 U.K.
7.3.2.1 U.K. Pediatric clinical trials market, 2018 - 2030 (USD Million)
7.3.3 Germany
7.3.3.1 Germany Pediatric clinical trials market, 2018 - 2030 (USD Million)
7.3.4 France
7.3.4.1 France Pediatric clinical trials market, 2018 - 2030 (USD Million)
7.3.5 Italy
7.3.5.1 Italy Pediatric clinical trials market, 2018 - 2030 (USD Million)
7.3.6 Spain
7.3.6.1 Spain Pediatric clinical trials market, 2018 - 2030(USD Million)
7.4 Asia Pacific
7.4.1 Asia Pacific Pediatric clinical trials market, 2018 - 2030 (USD Million)
7.4.2 India
7.4.2.1 India Pediatric clinical trials market, 2018 - 2030 (USD Million)
7.4.3 Japan
7.4.3.1 Japan Pediatric clinical trials market, 2018 - 2030 (USD Million)
7.4.4 China
7.4.4.1 China Pediatric clinical trials market, 2018 - 2030 (USD Million)
7.4.5 Thailand
7.4.5.1 Thailand Pediatric clinical trials market, 2018 - 2030 (USD Million)
7.4.6 South Korea
7.4.6.1 South Korea Pediatric clinical trials market, 2018 - 2030 (USD Million)
7.5 Latin America
7.5.1 Latin America Pediatric clinical trials market, 2018 - 2030 (USD Million)
7.5.2 Brazil
7.5.2.1 Brazil Pediatric clinical trials market, 2018 - 2030 (USD Million)
7.5.3 Mexico
7.5.3.1 Mexico Pediatric clinical trials market, 2018 - 2030 (USD Million)
7.5.4 Argentina
7.5.4.1 Argentina Pediatric clinical trials market, 2018 - 2030 (USD Million)
7.5.5 Colombia
7.5.5.1 Colombia Pediatric clinical trials market, 2018 - 2030 (USD Million)
7.6 MEA
7.6.1 MEA Pediatric clinical trials market, 2018 - 2030 (USD Million)
7.6.2 South Africa
7.6.2.1 South Africa Pediatric clinical trials market, 2018 - 2030 (USD Million)
7.6.3 Saudi Arabia
7.6.3.1 Saudi Arabia Pediatric clinical trials market, 2018 - 2030 (USD Million)
7.6.4 UAE
7.6.4.1 UAE Pediatric clinical trials market, 2018 - 2030 (USD Million)
CHAPTER 8 COMPANY PROFILES
8.1 Company Profiles
8.1.1 ICON plc
8.1.1.1 Company overview
8.1.1.2 Financial performance
8.1.1.3 Service benchmarking
8.1.2 Syneos Health
8.1.2.1 Company overview
8.1.2.2 Financial performance
8.1.2.3 Service benchmarking
8.1.2.4 Strategic initiatives
8.1.3 Medpace, Inc.
8.1.3.1 Company overview
8.1.3.2 Financial performance
8.1.3.3 Product benchmarking
8.1.3.4 Strategic initiatives
8.1.4 PPD Inc.
8.1.4.1 Company overview
8.1.4.2 Product benchmarking
8.1.4.3 Strategic initiatives
8.1.5 Premier Research
8.1.5.1 Company overview
8.1.5.2 Product benchmarking
8.1.5.3 Strategic initiatives
8.1.6 LabCorp Drug Development
8.1.6.1 Company overview
8.1.6.2 Financial performance
8.1.6.3 Product benchmarking
8.1.6.4 Strategic initiatives
8.1.7 QPS Holdings.
8.1.7.1 Company overview
8.1.7.2 Financial performance
8.1.7.3 Product benchmarking
8.1.8 Pfizer Inc.
8.1.8.1 Company overview
8.1.8.2 Financial performance
8.1.8.3 Product benchmarking
8.1.9 The Emmes Company, LLC
8.1.9.1 Company overview
8.1.9.2 Financial performance
8.1.9.3 Product benchmarking
8.1.9.4 Strategic Initiatives
8.1.10 IQVIA Inc.
8.1.10.1 Company overview
8.1.10.2 Financial performance
8.1.10.3 Product benchmarking
8.1.10.4 Strategic Initiatives
LIST OF TABLES
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global Pediatric Clinical Trials Market, by region, 2018 - 2030 (USD Million)
Table 4 Global Pediatric Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 5 Global Pediatric Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 6 Global Pediatric Clinical Trials Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 7 North America Pediatric Clinical Trials Market, by Country, 2018 - 2030 (USD Million)
Table 8 North America Pediatric Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 9 North America Pediatric Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 10 North America Pediatric Clinical Trials Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 11 U.S. Pediatric Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 12 U.S. Pediatric Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 13 U.S. Pediatric Clinical Trials Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 14 Canada Pediatric Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 15 Canada Pediatric Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 16 Canada Pediatric Clinical Trials Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 17 Europe Pediatric Clinical Trials Market, by Country, 2018 - 2030 (USD Million)
Table 18 Europe Pediatric Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 19 Europe Pediatric Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 20 Europe Pediatric Clinical Trials Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 21 U.K. Pediatric Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 22 U.K. Pediatric Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 23 U.K. Pediatric Clinical Trials Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 24 Germany Pediatric Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 25 Germany Pediatric Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 26 Germany Pediatric Clinical Trials Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 27 France Pediatric Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 28 France Pediatric Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 29 France Pediatric Clinical Trials Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 30 Italy Pediatric Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 31 Italy Pediatric Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 32 Italy Pediatric Clinical Trials Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 33 Spain Pediatric Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 34 Spain Pediatric Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 35 Spain Pediatric Clinical Trials Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 36 Asia pacific Pediatric Clinical Trials Market, by Country, 2018 - 2030 (USD Million)
Table 37 Asia pacific Pediatric Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 38 Asia pacific Pediatric Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 39 Asia pacific Pediatric Clinical Trials Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 40 Japan Pediatric Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 41 Japan Pediatric Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 42 Japan Pediatric Clinical Trials Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 43 India Pediatric Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 44 India Pediatric Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 45 India Pediatric Clinical Trials Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 46 China Pediatric Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 47 China Pediatric Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 48 China Pediatric Clinical Trials Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 49 Thailand Pediatric Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 50 Thailand Pediatric Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 51 Thailand Pediatric Clinical Trials Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 52 South Korea Pediatric Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 53 South Korea Pediatric Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 54 South Korea Pediatric Clinical Trials Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 55 Latin America Pediatric Clinical Trials Market, by Country, 2018 - 2030 (USD Million)
Table 56 Latin America Pediatric Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 57 Latin America Pediatric Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 58 Latin America Pediatric Clinical Trials Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 59 Brazil Pediatric Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 60 Brazil Pediatric Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 61 Brazil Pediatric Clinical Trials Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 62 Mexico Pediatric Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 63 Mexico Pediatric Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 64 Mexico Pediatric Clinical Trials Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 65 Argentina Pediatric Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 66 Argentina Pediatric Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 67 Argentina Pediatric Clinical Trials Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 68 Colombia Pediatric Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 69 Colombia Pediatric Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 70 Colombia Pediatric Clinical Trials Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 71 MEA Pediatric Clinical Trials Market, by Country, 2018 - 2030 (USD Million)
Table 72 MEA Pediatric Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 73 MEA Pediatric Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 74 MEA Pediatric Clinical Trials Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 75 South Africa Pediatric Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 76 South Africa Pediatric Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 77 South Africa Pediatric Clinical Trials Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 78 South Arabia Pediatric Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 79 South Arabia Pediatric Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 80 South Arabia Pediatric Clinical Trials Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 81 UAE Pediatric Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 82 UAE Pediatric Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 83 UAE Pediatric Clinical Trials Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global Pediatric Clinical Trials Market, by region, 2018 - 2030 (USD Million)
Table 4 Global Pediatric Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 5 Global Pediatric Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 6 Global Pediatric Clinical Trials Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 7 North America Pediatric Clinical Trials Market, by Country, 2018 - 2030 (USD Million)
Table 8 North America Pediatric Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 9 North America Pediatric Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 10 North America Pediatric Clinical Trials Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 11 U.S. Pediatric Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 12 U.S. Pediatric Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 13 U.S. Pediatric Clinical Trials Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 14 Canada Pediatric Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 15 Canada Pediatric Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 16 Canada Pediatric Clinical Trials Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 17 Europe Pediatric Clinical Trials Market, by Country, 2018 - 2030 (USD Million)
Table 18 Europe Pediatric Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 19 Europe Pediatric Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 20 Europe Pediatric Clinical Trials Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 21 U.K. Pediatric Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 22 U.K. Pediatric Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 23 U.K. Pediatric Clinical Trials Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 24 Germany Pediatric Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 25 Germany Pediatric Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 26 Germany Pediatric Clinical Trials Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 27 France Pediatric Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 28 France Pediatric Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 29 France Pediatric Clinical Trials Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 30 Italy Pediatric Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 31 Italy Pediatric Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 32 Italy Pediatric Clinical Trials Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 33 Spain Pediatric Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 34 Spain Pediatric Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 35 Spain Pediatric Clinical Trials Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 36 Asia pacific Pediatric Clinical Trials Market, by Country, 2018 - 2030 (USD Million)
Table 37 Asia pacific Pediatric Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 38 Asia pacific Pediatric Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 39 Asia pacific Pediatric Clinical Trials Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 40 Japan Pediatric Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 41 Japan Pediatric Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 42 Japan Pediatric Clinical Trials Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 43 India Pediatric Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 44 India Pediatric Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 45 India Pediatric Clinical Trials Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 46 China Pediatric Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 47 China Pediatric Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 48 China Pediatric Clinical Trials Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 49 Thailand Pediatric Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 50 Thailand Pediatric Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 51 Thailand Pediatric Clinical Trials Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 52 South Korea Pediatric Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 53 South Korea Pediatric Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 54 South Korea Pediatric Clinical Trials Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 55 Latin America Pediatric Clinical Trials Market, by Country, 2018 - 2030 (USD Million)
Table 56 Latin America Pediatric Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 57 Latin America Pediatric Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 58 Latin America Pediatric Clinical Trials Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 59 Brazil Pediatric Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 60 Brazil Pediatric Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 61 Brazil Pediatric Clinical Trials Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 62 Mexico Pediatric Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 63 Mexico Pediatric Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 64 Mexico Pediatric Clinical Trials Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 65 Argentina Pediatric Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 66 Argentina Pediatric Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 67 Argentina Pediatric Clinical Trials Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 68 Colombia Pediatric Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 69 Colombia Pediatric Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 70 Colombia Pediatric Clinical Trials Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 71 MEA Pediatric Clinical Trials Market, by Country, 2018 - 2030 (USD Million)
Table 72 MEA Pediatric Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 73 MEA Pediatric Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 74 MEA Pediatric Clinical Trials Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 75 South Africa Pediatric Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 76 South Africa Pediatric Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 77 South Africa Pediatric Clinical Trials Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 78 South Arabia Pediatric Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 79 South Arabia Pediatric Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 80 South Arabia Pediatric Clinical Trials Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
Table 81 UAE Pediatric Clinical Trials Market, by Phase, 2018 - 2030 (USD Million)
Table 82 UAE Pediatric Clinical Trials Market, by Study Design, 2018 - 2030 (USD Million)
Table 83 UAE Pediatric Clinical Trials Market, by Therapeutic Areas, 2018 - 2030 (USD Million)
LIST OF FIGURES
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Pediatric clinical trials market snapshot (2021)
Fig. 6 Pediatric clinical trials market segmentation
Fig. 7 Parent market outlook
Fig. 8 Related/ancillary market outlook
Fig. 9 Penetration & growth prospect mapping
Fig. 10 Market driver relevance analysis (Current & future impact)
Fig. 11 Market restraint relevance analysis (Current & future impact)
Fig. 12 Porter’s five forces analysis
Fig. 13 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 14 Pediatric clinical trials market: Phase dashboard
Fig. 15 Pediatric clinical trials market: Phase movement analysis
Fig. 16 Phase I market, 2018 - 2030 (USD Million)
Fig. 17 Phase II market, 2018 - 2030 (USD Million)
Fig. 18 Phase III market, 2018 - 2030 (USD Million)
Fig. 19 Phase IV market, 2018 - 2030 (USD Million)
Fig. 20 Pediatric clinical trials market outlook: study design dashboard
Fig. 21 Pediatric clinical trials market: study design movement analysis
Fig. 22 Treatment studies market, 2018 - 2030 (USD Million)
Fig. 23 Observational studies market, 2018 - 2030 (USD Million)
Fig. 24 Pediatric clinical trials market: Therapeutic Areas movement analysis
Fig. 25 Infectious Diseases market, 2018 - 2030 (USD Million)
Fig. 26 Oncology market, 2018 - 2030 (USD Million)
Fig. 27 Autoimmune / inflammatory diseases market, 2018 - 2030 (USD Million)
Fig. 28 Respiratory disorders market, 2018 - 2030 (USD Million)
Fig. 29 Mental health disorders market, 2018 - 2030 (USD Million)
Fig. 30 Others market, 2018 - 2030 (USD Million)
Fig. 31 Global Pediatric Clinical Trials market, 2018 - 2030 (USD Million)
Fig. 32 North America Pediatric Clinical Trials market, 2018 - 2030 (USD Million)
Fig. 33 U.S. Pediatric Clinical Trials market, 2018 - 2030 (USD Million)
Fig. 34 Canada Pediatric Clinical Trials market, 2018 - 2030 (USD Million)
Fig. 35 Europe Pediatric Clinical Trials market, 2018 - 2030 (USD Million)
Fig. 36 U.K. Pediatric Clinical Trials market, 2018 - 2030 (USD Million)
Fig. 37 Germany Pediatric Clinical Trials market, 2018 - 2030 (USD Million)
Fig. 38 France Trial Site Management organization (SMO) market, 2018 - 2030 (USD Million)
Fig. 39 Italy Pediatric Clinical Trials market, 2018 - 2030 (USD Million)
Fig. 40 Spain Pediatric Clinical Trials market, 2018 - 2030 (USD Million)
Fig. 41 Asia Pacific Pediatric Clinical Trials market, 2018 - 2030 (USD Million)
Fig. 42 Japan Pediatric Clinical Trials market, 2018 - 2030 (USD Million)
Fig. 43 China Pediatric Clinical Trials market, 2018 - 2030 (USD Million)
Fig. 44 India Pediatric Clinical Trials market, 2018 - 2030 (USD Million)
Fig. 45 Thailand Pediatric Clinical Trials market, 2018 - 2030 (USD Million)
Fig. 46 South Korea Pediatric Clinical Trials market, 2018 - 2030 (USD Million)
Fig. 47 Latin America Pediatric Clinical Trials market, 2018 - 2030 (USD Million)
Fig. 48 Brazil Pediatric Clinical Trials market, 2018 - 2030 (USD Million)
Fig. 49 Mexico Pediatric Clinical Trials market, 2018 - 2030 (USD Million)
Fig. 50 Argentina Pediatric Clinical Trials market, 2018 - 2030 (USD Million)
Fig. 50 Colombia Pediatric Clinical Trials market, 2018 - 2030 (USD Million)
Fig. 51 Middle East & Africa Pediatric Clinical Trials market, 2018 - 2030 (USD Million)
Fig. 52 South Africa Pediatric Clinical Trials market, 2018 - 2030 (USD Million)
Fig. 53 Saudi Arabia Pediatric Clinical Trials market, 2018 - 2030 (USD Million)
Fig. 54 UAE Pediatric Clinical Trials market, 2018 - 2030 (USD Million)
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Pediatric clinical trials market snapshot (2021)
Fig. 6 Pediatric clinical trials market segmentation
Fig. 7 Parent market outlook
Fig. 8 Related/ancillary market outlook
Fig. 9 Penetration & growth prospect mapping
Fig. 10 Market driver relevance analysis (Current & future impact)
Fig. 11 Market restraint relevance analysis (Current & future impact)
Fig. 12 Porter’s five forces analysis
Fig. 13 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 14 Pediatric clinical trials market: Phase dashboard
Fig. 15 Pediatric clinical trials market: Phase movement analysis
Fig. 16 Phase I market, 2018 - 2030 (USD Million)
Fig. 17 Phase II market, 2018 - 2030 (USD Million)
Fig. 18 Phase III market, 2018 - 2030 (USD Million)
Fig. 19 Phase IV market, 2018 - 2030 (USD Million)
Fig. 20 Pediatric clinical trials market outlook: study design dashboard
Fig. 21 Pediatric clinical trials market: study design movement analysis
Fig. 22 Treatment studies market, 2018 - 2030 (USD Million)
Fig. 23 Observational studies market, 2018 - 2030 (USD Million)
Fig. 24 Pediatric clinical trials market: Therapeutic Areas movement analysis
Fig. 25 Infectious Diseases market, 2018 - 2030 (USD Million)
Fig. 26 Oncology market, 2018 - 2030 (USD Million)
Fig. 27 Autoimmune / inflammatory diseases market, 2018 - 2030 (USD Million)
Fig. 28 Respiratory disorders market, 2018 - 2030 (USD Million)
Fig. 29 Mental health disorders market, 2018 - 2030 (USD Million)
Fig. 30 Others market, 2018 - 2030 (USD Million)
Fig. 31 Global Pediatric Clinical Trials market, 2018 - 2030 (USD Million)
Fig. 32 North America Pediatric Clinical Trials market, 2018 - 2030 (USD Million)
Fig. 33 U.S. Pediatric Clinical Trials market, 2018 - 2030 (USD Million)
Fig. 34 Canada Pediatric Clinical Trials market, 2018 - 2030 (USD Million)
Fig. 35 Europe Pediatric Clinical Trials market, 2018 - 2030 (USD Million)
Fig. 36 U.K. Pediatric Clinical Trials market, 2018 - 2030 (USD Million)
Fig. 37 Germany Pediatric Clinical Trials market, 2018 - 2030 (USD Million)
Fig. 38 France Trial Site Management organization (SMO) market, 2018 - 2030 (USD Million)
Fig. 39 Italy Pediatric Clinical Trials market, 2018 - 2030 (USD Million)
Fig. 40 Spain Pediatric Clinical Trials market, 2018 - 2030 (USD Million)
Fig. 41 Asia Pacific Pediatric Clinical Trials market, 2018 - 2030 (USD Million)
Fig. 42 Japan Pediatric Clinical Trials market, 2018 - 2030 (USD Million)
Fig. 43 China Pediatric Clinical Trials market, 2018 - 2030 (USD Million)
Fig. 44 India Pediatric Clinical Trials market, 2018 - 2030 (USD Million)
Fig. 45 Thailand Pediatric Clinical Trials market, 2018 - 2030 (USD Million)
Fig. 46 South Korea Pediatric Clinical Trials market, 2018 - 2030 (USD Million)
Fig. 47 Latin America Pediatric Clinical Trials market, 2018 - 2030 (USD Million)
Fig. 48 Brazil Pediatric Clinical Trials market, 2018 - 2030 (USD Million)
Fig. 49 Mexico Pediatric Clinical Trials market, 2018 - 2030 (USD Million)
Fig. 50 Argentina Pediatric Clinical Trials market, 2018 - 2030 (USD Million)
Fig. 50 Colombia Pediatric Clinical Trials market, 2018 - 2030 (USD Million)
Fig. 51 Middle East & Africa Pediatric Clinical Trials market, 2018 - 2030 (USD Million)
Fig. 52 South Africa Pediatric Clinical Trials market, 2018 - 2030 (USD Million)
Fig. 53 Saudi Arabia Pediatric Clinical Trials market, 2018 - 2030 (USD Million)
Fig. 54 UAE Pediatric Clinical Trials market, 2018 - 2030 (USD Million)
